table of content
1 Study Coverage
1.1 Oncology (Anti-cancer Drugs) Product Introduction
1.2 Global Oncology (Anti-cancer Drugs) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Oncology (Anti-cancer Drugs) Sales in US$ Million for the Year 2017-2028
1.2.2 Global Oncology (Anti-cancer Drugs) Sales in Volume for the Year 2017-2028
1.3 United States Oncology (Anti-cancer Drugs) Outlook 2017 VS 2022 VS 2028
1.3.1 United States Oncology (Anti-cancer Drugs) Sales in US$ Million for the Year 2017-2028
1.3.2 United States Oncology (Anti-cancer Drugs) Sales in Volume for the Year 2017-2028
1.4 Oncology (Anti-cancer Drugs) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Oncology (Anti-cancer Drugs) in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Oncology (Anti-cancer Drugs) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Oncology (Anti-cancer Drugs) Market Dynamics
1.5.1 Oncology (Anti-cancer Drugs) Industry Trends
1.5.2 Oncology (Anti-cancer Drugs) Market Drivers
1.5.3 Oncology (Anti-cancer Drugs) Market Challenges
1.5.4 Oncology (Anti-cancer Drugs) Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Oncology (Anti-cancer Drugs) Market Segment by Type
2.1.1 Blood Cancer
2.1.2 Breast Cancer
2.1.3 Gastrointestinal Cancer
2.1.4 Prostate Cancer
2.1.5 Others
2.2 Global Oncology (Anti-cancer Drugs) Market Size by Type
2.2.1 Global Oncology (Anti-cancer Drugs) Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Oncology (Anti-cancer Drugs) Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Oncology (Anti-cancer Drugs) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Oncology (Anti-cancer Drugs) Market Size by Type
2.3.1 United States Oncology (Anti-cancer Drugs) Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Oncology (Anti-cancer Drugs) Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Oncology (Anti-cancer Drugs) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Oncology (Anti-cancer Drugs) Market Segment by Application
3.1.1 Chemotherapy
3.1.2 Targeted Therapy
3.1.3 Immunotherapy (Biologic Therapy)
3.1.4 Hormonal Therapy
3.1.5 Others
3.2 Global Oncology (Anti-cancer Drugs) Market Size by Application
3.2.1 Global Oncology (Anti-cancer Drugs) Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Oncology (Anti-cancer Drugs) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Oncology (Anti-cancer Drugs) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Oncology (Anti-cancer Drugs) Market Size by Application
3.3.1 United States Oncology (Anti-cancer Drugs) Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Oncology (Anti-cancer Drugs) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Oncology (Anti-cancer Drugs) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Oncology (Anti-cancer Drugs) Competitor Landscape by Company
4.1 Global Oncology (Anti-cancer Drugs) Market Size by Company
4.1.1 Top Global Oncology (Anti-cancer Drugs) Manufacturers Ranked by Revenue (2021)
4.1.2 Global Oncology (Anti-cancer Drugs) Revenue by Manufacturer (2017-2022)
4.1.3 Global Oncology (Anti-cancer Drugs) Sales by Manufacturer (2017-2022)
4.1.4 Global Oncology (Anti-cancer Drugs) Price by Manufacturer (2017-2022)
4.2 Global Oncology (Anti-cancer Drugs) Concentration Ratio (CR)
4.2.1 Oncology (Anti-cancer Drugs) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oncology (Anti-cancer Drugs) in 2021
4.2.3 Global Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Oncology (Anti-cancer Drugs) Manufacturing Base Distribution, Product Type
4.3.1 Global Oncology (Anti-cancer Drugs) Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Oncology (Anti-cancer Drugs) Product Type
4.3.3 Date of International Manufacturers Enter into Oncology (Anti-cancer Drugs) Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Oncology (Anti-cancer Drugs) Market Size by Company
4.5.1 Top Oncology (Anti-cancer Drugs) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Oncology (Anti-cancer Drugs) Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Oncology (Anti-cancer Drugs) Sales by Players (2020, 2021 & 2022)
5 Global Oncology (Anti-cancer Drugs) Market Size by Region
5.1 Global Oncology (Anti-cancer Drugs) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Oncology (Anti-cancer Drugs) Market Size in Volume by Region (2017-2028)
5.2.1 Global Oncology (Anti-cancer Drugs) Sales in Volume by Region: 2017-2022
5.2.2 Global Oncology (Anti-cancer Drugs) Sales in Volume Forecast by Region (2023-2028)
5.3 Global Oncology (Anti-cancer Drugs) Market Size in Value by Region (2017-2028)
5.3.1 Global Oncology (Anti-cancer Drugs) Sales in Value by Region: 2017-2022
5.3.2 Global Oncology (Anti-cancer Drugs) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Oncology (Anti-cancer Drugs) Market Size YoY Growth 2017-2028
6.1.2 North America Oncology (Anti-cancer Drugs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Oncology (Anti-cancer Drugs) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Oncology (Anti-cancer Drugs) Market Size YoY Growth 2017-2028
6.3.2 Europe Oncology (Anti-cancer Drugs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Oncology (Anti-cancer Drugs) Market Size YoY Growth 2017-2028
6.4.2 Latin America Oncology (Anti-cancer Drugs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Oncology (Anti-cancer Drugs) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Oncology (Anti-cancer Drugs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Roche
7.1.1 Roche Corporation Information
7.1.2 Roche Description and Business Overview
7.1.3 Roche Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Roche Oncology (Anti-cancer Drugs) Products Offered
7.1.5 Roche Recent Development
7.2 Novartis
7.2.1 Novartis Corporation Information
7.2.2 Novartis Description and Business Overview
7.2.3 Novartis Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Novartis Oncology (Anti-cancer Drugs) Products Offered
7.2.5 Novartis Recent Development
7.3 Celgene
7.3.1 Celgene Corporation Information
7.3.2 Celgene Description and Business Overview
7.3.3 Celgene Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Celgene Oncology (Anti-cancer Drugs) Products Offered
7.3.5 Celgene Recent Development
7.4 Amgen
7.4.1 Amgen Corporation Information
7.4.2 Amgen Description and Business Overview
7.4.3 Amgen Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Amgen Oncology (Anti-cancer Drugs) Products Offered
7.4.5 Amgen Recent Development
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporation Information
7.5.2 Johnson & Johnson Description and Business Overview
7.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Johnson & Johnson Oncology (Anti-cancer Drugs) Products Offered
7.5.5 Johnson & Johnson Recent Development
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporation Information
7.6.2 GlaxoSmithKline Description and Business Overview
7.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.6.4 GlaxoSmithKline Oncology (Anti-cancer Drugs) Products Offered
7.6.5 GlaxoSmithKline Recent Development
7.7 Eli lilly & Co
7.7.1 Eli lilly & Co Corporation Information
7.7.2 Eli lilly & Co Description and Business Overview
7.7.3 Eli lilly & Co Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Eli lilly & Co Oncology (Anti-cancer Drugs) Products Offered
7.7.5 Eli lilly & Co Recent Development
7.8 Pfizer
7.8.1 Pfizer Corporation Information
7.8.2 Pfizer Description and Business Overview
7.8.3 Pfizer Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Pfizer Oncology (Anti-cancer Drugs) Products Offered
7.8.5 Pfizer Recent Development
7.9 Merck & Co.
7.9.1 Merck & Co. Corporation Information
7.9.2 Merck & Co. Description and Business Overview
7.9.3 Merck & Co. Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Merck & Co. Oncology (Anti-cancer Drugs) Products Offered
7.9.5 Merck & Co. Recent Development
7.10 Sanofi
7.10.1 Sanofi Corporation Information
7.10.2 Sanofi Description and Business Overview
7.10.3 Sanofi Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Sanofi Oncology (Anti-cancer Drugs) Products Offered
7.10.5 Sanofi Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Oncology (Anti-cancer Drugs) Industry Chain Analysis
8.2 Oncology (Anti-cancer Drugs) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Oncology (Anti-cancer Drugs) Distributors
8.3 Oncology (Anti-cancer Drugs) Production Mode & Process
8.4 Oncology (Anti-cancer Drugs) Sales and Marketing
8.4.1 Oncology (Anti-cancer Drugs) Sales Channels
8.4.2 Oncology (Anti-cancer Drugs) Distributors
8.5 Oncology (Anti-cancer Drugs) Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
